Trial Profile
Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 12 Feb 2021
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Pharmacodynamics
- 09 Feb 2021 Status changed from active, no longer recruiting to completed.
- 26 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 19 May 2015 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2017, according to to ClinicalTrials.gov record.